-
Carvana Q4 Earnings Preview: Improving Profitability, Growing Revenue, EV Sales Top Items To Watch
Tuesday, February 18, 2025 - 9:37pm | 938Used car online retailer Carvana Co (NYSE:CVNA) looks to keep its streak of profitability and analyst beats intact when the company reports fourth-quarter financial results after market close Wednesday. Here's a look at the earnings estimates from analysts and key items to watch. Earnings Estimates...
-
Kerrisdale Short Report Says St. Joe's Real Estate Plan 'Pure Fantasy'
Tuesday, April 24, 2018 - 3:15pm | 348St. Joe Co (NYSE: JOE) plunged as much as 5 percent Tuesday after Kerrisdale Capital issued a short report on the firm’s “overhyped real estate holdings.” “The bull thesis for St. Joe rests on the company’s ability to transform remote land, which no one can...
-
Speculative Short To M&A Darling, A Look Back At StraightPath Communications Journey
Monday, May 8, 2017 - 2:29pm | 803Straight Path Communications Inc (NYSE: STRP) shares have been on the high since early April after AT&T Inc. (NYSE: T) clinched a $1.6 billion all-stock buyout deal for the company, valuing it at $95.63 per share. The stock was rangebound for a long time in the run-up to the announcement. Since...
-
Kerrisdale Capital Short Thesis On Sage Therapeutics: Lead Drug 'Likely To Fail' In Phase 3
Wednesday, March 23, 2016 - 9:28am | 511Kerrisdale Capital stated that in addition to a negative report, SAGE Therapeutics Inc (NASDAQ: SAGE)'s lead drug candidate "is likely to fail in Phase 3." "While Sage bulls sometimes suggest that SAGE-547 can cure SRSE, a condition in which patients have long or recurrent...
-
Kerrisdale Short Zafgen, Says Beloranib Has 'No Reasonable Chance' Of FDA Approval And Recent Bullishness Is 'Misplaced'
Monday, January 25, 2016 - 10:36am | 551Zafgen Inc (NASDAQ: ZFGN) shares are up 41 percent in the last five trading days amid positive data for beloranib's ability to treat weight loss in patients with Prader-Willi syndrome. In a new report Monday morning, hedge fund Kerrisdale Capital said it is short the stock with a $3 price...
-
Shares Of Five Below Drop Following Negative Report By Kerrisdale
Thursday, June 12, 2014 - 12:25pm | 180Kerrisdale Capital published a negative blog post on Five Below (NASDAQ: FIVE). Following the post from the known-bearish firm, shares of Five Below were trading down just over three percent. The blog began, "We believe that Five Below is highly overvalued." However, above this was a...